151 related articles for article (PubMed ID: 16840174)
1. Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium.
Sander TL; Noll L; Klinkner DB; Weihrauch D; He BJ; Kaul S; Zangwill SD; Tweddell JS; Pritchard KA; Oldham KT
Endothelium; 2006; 13(3):181-90. PubMed ID: 16840174
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function.
Klinkner DB; Densmore JC; Kaul S; Noll L; Lim HJ; Weihrauch D; Pritchard KA; Oldham KT; Sander TL
Shock; 2006 Jun; 25(6):575-80. PubMed ID: 16721264
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.
Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM
Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130
[TBL] [Abstract][Full Text] [Related]
5. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
6. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
7. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
Lombardi A; Cantini G; Piscitelli E; Gelmini S; Francalanci M; Mello T; Ceni E; Varano G; Forti G; Rotondi M; Galli A; Serio M; Luconi M
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):718-24. PubMed ID: 18239149
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
[TBL] [Abstract][Full Text] [Related]
9. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
Desouza CV; Gerety M; Hamel FG
Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
[TBL] [Abstract][Full Text] [Related]
10. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
Cheng Y; Ping J; Xu LM
Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
[TBL] [Abstract][Full Text] [Related]
11. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
Dardik R; Inbal A
Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
Tencer L; Burgermeister E; Ebert MP; Liscovitch M
Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
[TBL] [Abstract][Full Text] [Related]
15. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
Duan SZ; Usher MG; Mortensen RM
Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
[TBL] [Abstract][Full Text] [Related]
18. Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways.
Zhao J; Zhao L; Chen W; He L; Li X
Biomed Pharmacother; 2008; 62(6):383-9. PubMed ID: 17826025
[TBL] [Abstract][Full Text] [Related]
19. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
20. Differential functions of genes regulated by VEGF-NFATc1 signaling pathway in the migration of pulmonary valve endothelial cells.
Jang GH; Park IS; Yang JH; Bischoff J; Lee YM
FEBS Lett; 2010 Jan; 584(1):141-6. PubMed ID: 19914243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]